Diagnosis and treatment of pheochromocytoma.
D000008:Abdominal Neoplasms / Q000175:diagnosis / Q000628:therapy; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists; D002277:Carcinoma / Q000150:complications; D002395:Catecholamines; D003937:Diagnosis, Differential; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006729:Hormones, Ectopic / Q000378:metabolism; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000235:genetics / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000401:mortality; D011859:Radiography; D013964:Thyroid Neoplasms / Q000150:complications; D014443:Tyrosine / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D006729:Hormones, Ectopic; D010643:Phenoxybenzamine; D014443:Tyrosine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine